Lloyd Czaplewski in

Lloyd Czaplewski

Login to view DISC.
Chair Scientific Projects Advisory Group (SPAG) at PACE-AMR
📍 Abingdon-On-Thames, England, United Kingdom

Lloyd Czaplewski is an entrepreneurial scientist with over 35 years of R&D experience in biological and chemical entities. As Chief Scientific Officer at Persica Pharmaceuticals and Director at Chemical Biology Ventures, he focuses on antibacterial research and novel therapies. He is a Fellow of the Royal Society of Chemistry and holds a degree from the University of East Anglia.

Lloyd has a deep interest in the translation of research into tangible therapies, a passion that has driven his career in the biotech industry. He enjoys working with diverse teams on projects that span from concept to clinical evaluation, viewing such opportunities as career highlights, particularly in developing treatments for debilitating conditions.

He won the Elsevier Atlas Award in March 2016 for his influential review on "Alternatives to Antibiotics, " recognizing its potential global impact.

Read the full overview →
Experience
43 Years
Current Role
Chair Scientific Projects Advisory Group (SPAG)
Job Level
Mid-senior
Location
Abingdon-On-Thames, England, United Kingdom
Personality Overview

How Lloyd shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Lloyd cares about

Combating AMR
A consistent focus of his career, evidenced by founding Abgentis, his role at PACE-AMR, his award-winning publication on antibiotic alternatives, and work with the WHO.
Chronic Pain Treatment
As CSO of Persica Pharmaceuticals, he is leading the clinical development of an innovative, non-symptomatic treatment (PP353) for chronic low back pain associated with Modic change.
+5 more topics Login to view topics
Career

Work history

4-2024
Chair Scientific Projects Advisory Group (SPAG)
PACE-AMR
7-2021 - 3-2023
Chair
Novo Repair Impact Scientific Selection Board
2014
CSO
Persica Pharmaceuticals Ltd
2-2012
Director
Chemical Biology Ventures Limited
2-2012 - 6-2019
Founder
Abgentis Limited
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1981 - 1984
Bachelor's degree
University of East Anglia
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Lloyd. Free, 10 seconds.